Probiotic may help prevent cognitive decline during aging

Coherus’ Yusimry was first approved in 2021 and is the seventh FDA-approved Humira biosimilar and Image Credit: Michael Vi / Shutterstock. Coherus BioSciences has divested

As­traZeneca has scored an FDA ap­proval for its AKT in­hibitor capi­vasert­ib, adding a new tar­get­ed ther­a­py to its treat­ment of­fer­ings in breast can­cer. The drug,

A 37-year-old woman went to the emergency department after 10 days of abdominal pain, and she eventually left a tertiary care hospital with her baby